{"id":1768,"date":"2026-05-07T15:42:25","date_gmt":"2026-05-07T15:42:25","guid":{"rendered":"https:\/\/gesmd.es\/?page_id=1768"},"modified":"2026-06-26T07:32:35","modified_gmt":"2026-06-26T07:32:35","slug":"becas","status":"publish","type":"page","link":"https:\/\/gesmd.es\/?page_id=1768","title":{"rendered":"BECAS"},"content":{"rendered":"\n
\n

Becas<\/h1><\/div>\n<\/div><\/div>\n\n\n\n
\n

Beca GESMD para investigaci\u00f3n en mielodisplasi<\/a>a<\/h2><\/div>\n\n\n\n

El objetivo de esta beca anual es impulsar proyectos de investigaci\u00f3n que contribuyan al desarrollo y fortalecimiento del GESMD, mejorando su funcionamiento y su capacidad para gestionar el Registro Espa\u00f1ol de S\u00edndromes Mielodispl\u00e1sicos (RESMD).<\/p>\n\n\n\n

A continuaci\u00f3n, se presentan los proyectos y beneficiarios de la beca desde su creaci\u00f3n.<\/p>\n\n\n\n

\n
\n
\"Beca<\/figure><\/div>\n<\/div>\n\n\n\n
\n

10\u00aa edici\u00f3n Beca GESMD \u2013 A\u00f1o 2026<\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/h4><\/div>\n\n\n\n

Cuant\u00eda:<\/mark> 25.000 \u20ac<\/strong>
Investigador:<\/mark> Juan Jos\u00e9 Rodr\u00edguez Sevilla, del Hospital Cl\u00ednic de Barcelona<\/strong>
T\u00edtulo:<\/mark> \u00abImpacto de la p\u00e9rdida del cromosoma Y en s\u00edndromes mielodispl\u00e1sicos: implicaciones cl\u00ednicas y reclasificaci\u00f3n pron\u00f3stica\u00bb<\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
\"Beca<\/figure><\/div>\n<\/div>\n\n\n\n
\n

9\u00aa edici\u00f3n Beca GESMD \u2013 A\u00f1o 2025<\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/h4><\/div>\n\n\n\n

Cuant\u00eda:<\/mark> 25.000 \u20ac<\/strong>
Investigador:<\/mark> Teresa Bernal del Castillo, del Hospital Universitario Central de Asturias<\/strong>
T\u00edtulo:<\/mark> \u00abFibrosis medular en s\u00edndromes mielodispl\u00e1sicos y leucemias agudas mieloides: mecanismos patog\u00e9nicos y oportunidades diagn\u00f3sticas\u00bb<\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
\"Beca<\/figure><\/div>\n<\/div>\n\n\n\n
\n

8\u00aa edici\u00f3n Beca GESMD \u2013 A\u00f1o 2024<\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/h4><\/div>\n\n\n\n

Cuant\u00eda:<\/mark> 20.000 \u20ac<\/strong>
Investigador:<\/mark> Dr. Adri\u00e1n Mosquera Orgueira, del Complexo Hospitalario Universitario de Santiago de Compostela<\/strong><\/strong>
T\u00edtulo:<\/mark> \u00abOptimizaci\u00f3n y validaci\u00f3n prospectiva del score AIPSS-MDS para la estratificaci\u00f3n de riesgo en s\u00edndromes mielodispl\u00e1sicos: hacia un modelo cl\u00ednico-molecular integrado\u00bb<\/strong><\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
\"Beca<\/figure><\/div>\n<\/div>\n\n\n\n
\n

7\u00aa edici\u00f3n Beca GESMD \u2013 A\u00f1o 2023<\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/h4><\/div>\n\n\n\n

Cuant\u00eda:<\/mark> 20.000 \u20ac<\/strong>
Investigador:<\/mark> Dra. Ana Alfonso, de la Cl\u00ednica Universidad de Navarra<\/strong><\/strong><\/strong>
T\u00edtulo:<\/mark> \u00abAn\u00e1lisis genot\u00edpico y fenot\u00edpico de c\u00e9lula \u00fanica de la enfermedad residual medible en los s\u00edndromes mielodispl\u00e1sicos\u00bb<\/strong><\/strong><\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
\"Beca<\/figure><\/div>\n<\/div>\n\n\n\n
\n

6\u00aa edici\u00f3n Beca GESMD \u2013 A\u00f1o 2022<\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/h4><\/div>\n\n\n\n

Cuant\u00eda:<\/mark> 20.000 \u20ac<\/strong>
Investigador:<\/mark> Dra. M\u00f3nica del Rey, del Centro de Investigaci\u00f3n del C\u00e1ncer de Salamanca<\/strong><\/strong><\/strong><\/strong>
T\u00edtulo:<\/mark> \u00abIncorporaci\u00f3n de la NGS a todos nuestros centros: caminando hacia la medicina personalizada en los SMD\u00bb<\/strong><\/strong><\/strong><\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
\"Beca<\/figure><\/div>\n<\/div>\n\n\n\n
\n

5\u00aa edici\u00f3n Beca GESMD \u2013 A\u00f1o 2021<\/strong><\/strong><\/strong><\/strong><\/strong><\/h4><\/div>\n\n\n\n

Cuant\u00eda:<\/mark> 15.000 \u20ac<\/strong>
Investigador:<\/mark> Dra. Alessandra Giorgetti, del IDIBELL<\/strong><\/strong><\/strong><\/strong><\/strong>
T\u00edtulo:<\/mark> \u00abEstudio de la transformaci\u00f3n leuc\u00e9mica de la deficiencia en GATA2 mediante t\u00e9cnicas \u00f3micas en modelos de c\u00e9lulas madre humanas\u00bb<\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
\"Beca<\/figure><\/div>\n<\/div>\n\n\n\n
\n

4\u00aa edici\u00f3n Beca GESMD \u2013 A\u00f1o 2020<\/strong><\/strong><\/strong><\/strong><\/h4><\/div>\n\n\n\n

Cuant\u00eda:<\/mark> 15.000 \u20ac<\/strong>
Investigador:<\/mark> Dra. Julia Montoro, del Hospital Universitario Vall d\u2019Hebron, y el Dr. Andr\u00e9s Jerez, del Hospital Universitario Morales Meseguer<\/strong><\/strong><\/strong><\/strong><\/strong><\/strong>
T\u00edtulo:<\/mark> \u00abCreaci\u00f3n de unas gu\u00edas nacionales y un biobanco de muestras de individuos con hematopoyesis clonal de potencial indeterminado (CHIP)\u00bb<\/strong><\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
\"Beca<\/figure><\/div>\n<\/div>\n\n\n\n
\n

3\u00aa edici\u00f3n Beca GESMD \u2013 A\u00f1o 2019<\/strong><\/strong><\/strong><\/h4><\/div>\n\n\n\n

Cuant\u00eda:<\/mark> 10.000 \u20ac<\/strong>
Investigador:<\/mark> Dr. Iv\u00e1n Mart\u00edn, del Hospital Cl\u00ednico Universitario de Valencia<\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong>
T\u00edtulo:<\/mark> \u00abS\u00edndromes mielodispl\u00e1sicos con deleci\u00f3n 20q: incidencia, valor pron\u00f3stico e impacto terap\u00e9utico de las deleciones cromos\u00f3micas del gen ASXL1, de otros genes pr\u00f3ximos y de las mutaciones gen\u00e9ticas\u00bb<\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
\"Beca<\/figure><\/div>\n<\/div>\n\n\n\n
\n

2\u00aa edici\u00f3n Beca GESMD \u2013 A\u00f1o 2017<\/strong><\/strong><\/h4><\/div>\n\n\n\n

Cuant\u00eda:<\/mark> 10.000 \u20ac<\/strong>
Investigador:<\/mark> Dra. Esperanza Such<\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong>
T\u00edtulo:<\/mark> \u00abEstandarizaci\u00f3n t\u00e9cnica de la NGS en el diagn\u00f3stico de s\u00edndromes mielodispl\u00e1sicos y leucemia mielomonoc\u00edtica cr\u00f3nica basada en las Gu\u00edas de NGS en SMD\u00bb<\/strong><\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
\"Beca<\/figure><\/div>\n<\/div>\n\n\n\n
\n

1\u00aa edici\u00f3n Beca GESMD \u2013 A\u00f1o 2016<\/strong><\/h4><\/div>\n\n\n\n

Cuant\u00eda:<\/mark> 10.000 \u20ac<\/strong>
Investigador:<\/mark> Dra. Esperanza Such y el Dr. Francesc Sol\u00e9<\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong>
T\u00edtulo:<\/mark> \u00abDesarrollo de una Gu\u00eda de Secuenciaci\u00f3n Masiva en S\u00edndromes Mielodispl\u00e1sicos y Leucemia Mielomonoc\u00edtica Cr\u00f3nica\u00bb<\/strong><\/p>\n<\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Becas Beca GESMD para investigaci\u00f3n en mielodisplasia El objetivo de esta beca anual es impulsar proyectos de investigaci\u00f3n que contribuyan […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-1768","page","type-page","status-publish","hentry"],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false},"uagb_author_info":{"display_name":"gesmd.jc.alvarez@ene.es","author_link":"https:\/\/gesmd.es\/?author=1"},"uagb_comment_info":0,"uagb_excerpt":"Becas Beca GESMD para investigaci\u00f3n en mielodisplasia El objetivo de esta beca anual es impulsar proyectos de investigaci\u00f3n que contribuyan […]","_links":{"self":[{"href":"https:\/\/gesmd.es\/index.php?rest_route=\/wp\/v2\/pages\/1768","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gesmd.es\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/gesmd.es\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/gesmd.es\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/gesmd.es\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1768"}],"version-history":[{"count":19,"href":"https:\/\/gesmd.es\/index.php?rest_route=\/wp\/v2\/pages\/1768\/revisions"}],"predecessor-version":[{"id":3436,"href":"https:\/\/gesmd.es\/index.php?rest_route=\/wp\/v2\/pages\/1768\/revisions\/3436"}],"wp:attachment":[{"href":"https:\/\/gesmd.es\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1768"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}